Treating Drug-Resistant Childhood Schizophrenia

• Status: Completed
• Trial end date: 2006-06-01

Summary

This study will compare clozapine and olanzapine (Zyprexa®) for the treatment of children and adolescents who have failed standard antipsychotic treatment for schizophrenia.

• Phase: Phase 4

Details

• Lead Sponsor: Northwell Health
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Clozapine; Olanzapine